15 Biggest Mid-Day Gainers For Thursday

Loading...
Loading...

 

  • Envirostar Inc EVI shares jumped 37.5 percent to $6.60 after the company reported the purchase of Western State Design for $28 million.
  • Euroseas Ltd. ESEA shares gained 19.5 percent to $2.21. Euroseas reported the cancelation of second Ultramax newbuilding vessel.
  • Repros Therapeutics Inc RPRX shares climbed 18.4 percent to $2.25 after the company announced positive results from its Phase 2 study evaluating Proellex (telapristone acetate) for severe endometriosis-related pain in premenopausal women.
  • Tailored Brands Inc TLRD surged 18.3 percent to $16.83 as the company reported stronger-than-expected results for its second quarter on Wednesday.
  • Clovis Oncology Inc CLVS shares surged 12.7 percent to $27.45. The FDA has notified Clovis that FDA is not currently planning to hold Advisory Committee Meeting to discuss the NDA for rucaparib.
  • Verint Systems Inc. VRNT shares surged 8.3 percent to $38.07. Verint announced better-than-expected quarterly earnings.
  • Sky Solar Holdings Ltd (ADR) SKYS shares gained 8.1 percent to $3.32 as the company delivered better than expected results for the second quarter.
  • Apigee Corp APIC shares gained 6.8 percent to $17.45. Apigee agreed to be purchased by Alphabet Inc's Google at $17.40 per share in cash.
  • Copa Holdings, S.A. CPA shares rose 6 percent to $84.27. Morgan Stanley upgraded Copa Holdings from Equal-weight to Overweight and raised the price target from $56.00 to $94.00.
  • Rite Aid Corporation RAD gained 5.4 percent to $8.17. Walgreens Boots Alliance Inc WBA said that it is exploring potential divestiture remedies to address certain issues raised during FTC discussions related to deal with Rite Aid.
  • Spectra Energy Corp. SE shares gained 5.3 percent to $43.72. CIBC upgraded Spectra Energy from Sector Performer to Sector Outperformer.
  • Abeona Therapeutics Inc ABEO shares rose 4.7 percent to $5.01. Abeona Therapeutics disclosed that it has enrolled 5th patient in Phase 1/2 gene therapy clinical trial for epidermolysis bullosa. Cantor Fitzgerald initiated coverage on Abeona Therapeutics with a Buy rating.
  • Enbridge Inc (USA) ENB gained 3.6 percent to $45.28. Goldman Sachs upgraded Enbridge from Neutral to Buy and raised the price target from $43 to $48.
  • Juno Therapeutics Inc JUNO shares rose 3 percent to $29.53 as the company reported the publication of JCAR014 clinical data in Science Translational Medicine.
  • LATAM Airlines Group SA (ADR) LFL gained 3 percent to $8.24. Morgan Stanley upgraded LATAM Airlines from Underweight to Equal-weight.
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsIntraday UpdateMarketsMoversAirlinesIndustrialsTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...